WGS
GeneDx Holdings Corp. · Healthcare · Medical - Diagnostics & Research
Nothing qualifies for this view in the current reporting period. Nothing here is placeholder data: when a figure exists in the filings, it appears.
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 1.53M | +6.6% | $164.74M | 0.0% | ▲ Add | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (被动) | 1.17M | -0.9% | $126.10M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Goldman Sachs Group ✦ | 1.17M | n/a | $125.86M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | Fidelity (FMR) ✦ | 503.31K | +208.2% | $54.23M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (被动) | 489.40K | +1.0% | $52.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 467.81K | n/a | $50.40M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 7 | ARK Investment Management ✦ | 446.98K | 新增 | $48.16M | 0.3% | New | 1 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (被动) | 439.81K | +5.7% | $47.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 395.73K | -2.7% | $42.64M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 10 | T. Rowe Price ✦ | 331.41K | +2101.3% | $35.71M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 190.94K | -29.9% | $20.57M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 130.43K | +6.3% | $14.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 55.59K | n/a | $5.99M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 14 | Millennium Management ✦ | 51.74K | 新增 | $5.57M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 28.74K | +21.2% | $3.10M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 16 | Marshall Wace ✦ | 8.49K | -33.1% | $914,497 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| ARK Investment Management | $48.16M | 0.3% |
| Millennium Management | $5.57M | 0.0% |
已清仓
| Norges Bank | $6.28M | 曾为 0.0% |
| Point72 Asset Management | $4.85M | 曾为 0.0% |
| D. E. Shaw & Co. | $845,098 | 曾为 0.0% |
| Gotham Asset Management | $414,841 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 240 持有人, 31.22M 股份, $1.98B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 3.04K 股 · $300,846
Officer · 1.08K 股 · $106,816
Officer, Director · 1.65K 股 · $155,337
Officer, Director · 148 股 · $14,120
Officer, Director · 1.52K 股 · $147,774
Officer, Director · 4.14K 股 · $406,936
Officer · 586 股 · $55,235
Officer · 52 股 · $4,961
Officer · 541 股 · $52,423
Officer · 1.47K 股 · $144,457
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
1.8% 占股份类别 · 查看 SEC 原始申报文件 ↗